vs
Dayforce(DAY)与Royalty Pharma plc(RPRX)财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Dayforce的1.3倍($622.0M vs $481.6M),Royalty Pharma plc净利率更高(34.4% vs -40.9%,领先75.3%),Dayforce同比增速更快(9.5% vs 4.8%),过去两年Dayforce的营收复合增速更高(9.8% vs 4.6%)
Dayforce前身为知名人力资源服务商Ceridian,是一家总部位于美国的人力资源软件及服务企业,面向各行业不同规模的客户提供覆盖薪酬核算、人员管理、考勤等多场景的HR SaaS产品及配套专业服务,助力企业提升人力资源运营效率。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业,专注于研发可调节转化生长因子β(TGF-β)超家族蛋白的药物,该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
DAY vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.3倍
$481.6M
营收增速更快
DAY
高出4.7%
4.8%
净利率更高
RPRX
高出75.3%
-40.9%
两年增速更快
DAY
近两年复合增速
4.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $481.6M | $622.0M |
| 净利润 | $-196.8M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 6.3% | 62.4% |
| 净利率 | -40.9% | 34.4% |
| 营收同比 | 9.5% | 4.8% |
| 净利润同比 | -9940.0% | 2.9% |
| 每股收益(稀释后) | $-1.23 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DAY
RPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | $481.6M | $609.3M | ||
| Q2 25 | $464.7M | $578.7M | ||
| Q1 25 | $481.8M | $568.2M | ||
| Q4 24 | $465.2M | $593.6M | ||
| Q3 24 | $440.0M | $564.7M | ||
| Q2 24 | $423.3M | $537.3M | ||
| Q1 24 | $431.5M | $568.0M |
净利润
DAY
RPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | $-196.8M | $288.2M | ||
| Q2 25 | $21.3M | $30.2M | ||
| Q1 25 | $14.9M | $238.3M | ||
| Q4 24 | $10.8M | $208.2M | ||
| Q3 24 | $2.0M | $544.0M | ||
| Q2 24 | $-1.8M | $102.0M | ||
| Q1 24 | $7.1M | $4.8M |
毛利率
DAY
RPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.0% | — | ||
| Q3 24 | 45.8% | — | ||
| Q2 24 | 44.1% | — | ||
| Q1 24 | 47.6% | — |
营业利润率
DAY
RPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | 6.3% | 70.1% | ||
| Q2 25 | 9.1% | 36.3% | ||
| Q1 25 | 6.4% | 94.0% | ||
| Q4 24 | 6.1% | 60.9% | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 3.3% | 50.2% | ||
| Q1 24 | 9.4% | -13.0% |
净利率
DAY
RPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | -40.9% | 47.3% | ||
| Q2 25 | 4.6% | 5.2% | ||
| Q1 25 | 3.1% | 41.9% | ||
| Q4 24 | 2.3% | 35.1% | ||
| Q3 24 | 0.5% | 96.3% | ||
| Q2 24 | -0.4% | 19.0% | ||
| Q1 24 | 1.6% | 0.8% |
每股收益(稀释后)
DAY
RPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | $-1.23 | $0.67 | ||
| Q2 25 | $0.13 | $0.07 | ||
| Q1 25 | $0.09 | $0.55 | ||
| Q4 24 | $0.07 | $0.46 | ||
| Q3 24 | $0.01 | $1.21 | ||
| Q2 24 | $-0.01 | $0.23 | ||
| Q1 24 | $0.04 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $627.6M | $618.7M |
| 总债务越低越好 | $631.1M | $9.0B |
| 股东权益账面价值 | $2.7B | $9.7B |
| 总资产 | $8.7B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.23× | 0.92× |
8季度趋势,按日历期对齐
现金及短期投资
DAY
RPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $627.6M | $938.9M | ||
| Q2 25 | $625.2M | $631.9M | ||
| Q1 25 | $557.3M | $1.1B | ||
| Q4 24 | $579.7M | $929.0M | ||
| Q3 24 | $494.1M | $950.1M | ||
| Q2 24 | $465.4M | $1.8B | ||
| Q1 24 | $392.5M | $843.0M |
总债务
DAY
RPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | $631.1M | $8.9B | ||
| Q2 25 | $631.8M | $8.0B | ||
| Q1 25 | $632.4M | $7.6B | ||
| Q4 24 | $1.2B | $7.6B | ||
| Q3 24 | $1.2B | $7.6B | ||
| Q2 24 | $1.2B | $7.6B | ||
| Q1 24 | $1.2B | $6.1B |
股东权益
DAY
RPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | $2.7B | $9.6B | ||
| Q2 25 | $2.7B | $9.5B | ||
| Q1 25 | $2.6B | $9.8B | ||
| Q4 24 | $2.5B | $10.3B | ||
| Q3 24 | $2.6B | $10.3B | ||
| Q2 24 | $2.5B | $9.8B | ||
| Q1 24 | $2.4B | $9.9B |
总资产
DAY
RPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | $8.7B | $19.3B | ||
| Q2 25 | $8.5B | $18.3B | ||
| Q1 25 | $9.5B | $17.6B | ||
| Q4 24 | $9.1B | $18.2B | ||
| Q3 24 | $8.1B | $18.0B | ||
| Q2 24 | $9.0B | $17.7B | ||
| Q1 24 | $10.8B | $16.1B |
负债/权益比
DAY
RPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | 0.23× | 0.93× | ||
| Q2 25 | 0.23× | 0.84× | ||
| Q1 25 | 0.24× | 0.78× | ||
| Q4 24 | 0.47× | 0.74× | ||
| Q3 24 | 0.47× | 0.74× | ||
| Q2 24 | 0.49× | 0.78× | ||
| Q1 24 | 0.50× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $31.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
DAY
RPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $31.2M | $702.6M | ||
| Q2 25 | $112.7M | $364.0M | ||
| Q1 25 | $49.6M | $596.1M | ||
| Q4 24 | $81.0M | $742.5M | ||
| Q3 24 | $91.8M | $703.6M | ||
| Q2 24 | $99.2M | $658.2M | ||
| Q1 24 | $9.1M | $664.6M |
现金转化率
DAY
RPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 5.29× | 12.06× | ||
| Q1 25 | 3.33× | 2.50× | ||
| Q4 24 | 7.50× | 3.57× | ||
| Q3 24 | 45.90× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 1.28× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |